Scientists from Spirovant Sciences describe SP-101, a novel adeno-associated virus (AAV) gene therapy for the treatment of cystic fibrosis (CF) in the peer-reviewed journal Human Gene Therapy.
SP-101 gene therapy shows promise for cystic fibrosis treatment
- Post author:
- Post published:September 9, 2024
- Post category:uncategorized